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Abstract  30 
 31 
Background 32 
Cardiac magnetic resonance (CMR) imaging may be used to visualize post-ablation atrial 33 
scar (PAAS), and three-dimensional late gadolinium enhancement (3D LGE) is the most 34 
widely employed technique for imaging of chronic scar. Detection of PAAS provides a 35 
unique non-invasive insight into the effects of the ablation and may help guide further 36 
ablation procedures. However, there is evidence that PAAS is often not detected even when 37 
present, implying a significant sensitivity problem, and imaging parameters vary between 38 
leading centres. Therefore, there is a need to establish the optimal imaging parameters to 39 
detect PAAS.  40 
 41 
Methods 42 
40 subjects undergoing first time ablation for AF had detailed CMR assessment of atrial scar: 43 
one scan pre-ablation, and two scans post-ablation at three months (separated by 48 44 
hours). Each scan session included ECG- and respiratory-navigated 3D LGE acquisition at 10, 45 
20 and 30min post injection of gadolinium-based contrast agent (GBCA). The first post-46 
procedural scan was performed on 1.5T scanner with standard acquisition parameters, 47 
including double dose (0.2mmol/kg) Gadovist and 4mm slice thickness. 10 patients 48 
subsequently underwent identical scan as controls, and the other 30 underwent imaging 49 
with a reduced, single, dose GBCA (n=10), half slice thickness (n=10) or on a 3T scanner 50 
(n=10). Apparent signal-to-noise (aSNR), contrast-to-noise (aCNR) and imaging quality 51 
(Likert Scale, 3 independent observers) were assessed. PAAS location and area (%PAAS scar) 52 
were assessed following manual segmentation. Atrial shells with standardised %PAAS at 53 
each timepoint were then compared to ablation lesion locations to assess quality of scar 54 
delineation. 55 
 56 
Results   57 
271 3D acquisitions (out of maximum 280, 96.7%) were acquired. Likert scale of imaging 58 
quality had high interobserver and intraobserver intraclass correlation coefficients (0.89 and 59 
0.96 respectively), and showed lower overall imaging quality on 3T and at half-slice 60 
thickness. aCNR, and quality of scar delineation increased significantly with time. aCNR was 61 
higher with reduced, single, dose of GBCA (p=0.005). 62 
 63 
Conclusion 64 
Atrial scar imaging, as assessed qualitatively and quantitatively, improves with time from 65 
GBCA administration, with some indices continuing to improve from 20 to 30min. Imaging 66 
should be performed at least 20min post-GBCA injection, and a single dose of contrast 67 
should be considered.  68 
 69 
Trial registry- United Kingdom National Research Ethics Service 08/H0802/68 – 30th 70 
September 2008 71 
 72 
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 76 
Background 77 
Over the last two decades there has been a substantial increase in the implementation of 78 
catheter ablation for the treatment of AF [1]. Concurrently, advances in CMR imaging have 79 
enabled clinically useful visualisation of the LA wall and ablation lesions [2–11]. However, 80 
arrhythmia recurrence rates post-ablation remain high, and many of these recurrences are 81 
secondary to pulmonary venous (PV) reconnection or linear lesion discontinuities following 82 
ineffective lesion formation [12]. Effective and reliable non-invasive assessment of post-83 
ablation atrial scar (PAAS) provides a unique insight into lesion formation and may help 84 
guide further ablation procedures. 85 
 86 
LGE acquisition techniques have been shown to be the most sensitive to detect PAAS [13], 87 
and can identify gaps in ablation lesion sets [14]. In 2009, Peters et al demonstrated that AF 88 
recurrence post-ablation correlates with the extent of PAAS [15]. This finding was 89 
corroborated by Badger et al in 2010, who found that complete encirclement of a PV by 90 
CMR-defined PAAS had a 100% positive predictive value in identifying electrical isolation [3]. 91 
However, the clinical implementation of these findings is controversial. In patients requiring 92 
repeat AF ablation procedure, some groups have shown good correlation between CMR-93 
derived lesion gaps and sites of successful re-isolation [7,11], whilst others have shown the 94 
opposite [9,16]. 95 
 96 
Consistent between all studies is the finding that complete encirclement of PVs by CMR-97 
detected PAAS is a rare occurrence. 90-100% of patients do not have complete encirclement 98 
of all PVs [2,3,7,11,16], in the context of a recurrence rate in these studies of 30-50%. In 99 
some cases, electrical reconnection will not result in AF recurrence [12,17], but on invasive 100 
assessment many of the veins remain electrically isolated, despite detection of gaps in CMR 101 
scar [7]. The specificity of PAAS gaps for electrical reconnection is low and therefore imaging 102 
techniques need to be optimized in order to maximize detection of effective ablation injury. 103 
 104 
The core imaging sequences have remained relatively unchanged from those first proposed 105 
and evaluated by the Boston and Utah groups [5,6]. For this, a gadolinium-based contrast 106 
agent (GBCA) is injected and the enhancing structures can be detected after a delay using an 107 
inversion recovery (IR) prepared 3D acquisition. The T1-weighted ECG- and respiratory-108 
navigated 3D turbo gradient echo sequence is widely available on most imaging platforms 109 
and moderately robust [18]. Novel sequences will continue to be developed and employed, 110 
but mainstream use of PAAS imaging in the medium term is highly likely to rely upon these 111 
conventional imaging techniques. However, the acquisition parameters vary widely 112 
between leading groups (see Table 1). Timing post- GBCA administration, scanner field 113 
strength, slice thickness and even GBCA dose differ.  114 
 115 
The measurement of improvement in imaging should ideally be referenced to a gold 116 
standard or hard clinical endpoint. For assessment of PAAS, there is no gold standard readily 117 
available. Comparison to invasive voltage mapping is prone to registration errors. 118 
Furthermore, voltage does not entirely reflect scar formation [19] and varies according to 119 
the electrode characteristics used to perform voltage mapping [20,21]. Alternatively, the 120 
clinical end-point of arrhythmia recurrence does not necessarily reflect a lack of PAAS in any 121 
given location [9]. This study, therefore, has sought to measure the improvement in imaging 122 
parameters through the assessment of conventional subjective and objective imaging 123 
quality markers in a prospective cross-over study. 124 
Methods 125 
Study population 126 
Between January 2014 and January 2016, all patients undergoing routine MR imaging prior 127 
to first-time AF ablation procedure were approached to join the study. 40 subjects provided 128 
written and informed consent and the study was approved by the National Research Ethics 129 
Service (South London Research Ethics Committee reference 08/H0802/68). Exclusion 130 
criteria were contraindication to MR imaging or prior allergic reaction to contrast agent. 131 
Baseline demographics and comorbidities were documented at the initial scan. 132 
 133 
All patients underwent CMR imaging on two occasions following clinically indicated catheter 134 
ablation for AF (Figure 1) The first post-ablation CMR scan (Scan 1) was performed at 135 
approximately three months after the ablation procedure, regardless of rhythm or 136 
arrhythmia recurrence (median 94 days, (interquartile range (IQR) 89-101 days)), and was 137 
performed using standard acquisition parameters (see below). A second scan session (Scan 138 
2) was performed approximately 2 days later (median 48.1 hours, IQR 47.9-49.1hours). 139 
Subjects were allocated to scan 2 in 3T scanner or the same 1.5T scanner. 3T scanner 140 
availability was limited, precluding randomization of allocation, but the allocation was 141 
performed without reference to patient outcome or demographics. The remaining patients 142 
were randomised in equal ratios to one of three different imaging parameter groups for 143 
scan 2: repeat scan with identical acquisition parameters, repeat with reduced, single, dose 144 
of GBCA, or repeat with half-slice thickness. 145 
CMR protocol 146 
CMR imaging was performed on a 1.5T MR-scanner (Ingenia, Philips Healthcare, Best, 147 
Netherlands), except for those allocated to 3T scanner for scan 2 (see below). All patients 148 
underwent detailed assessment at pre-procedural CMR scan, including left ventricular (LV) 149 
and right ventricular (RV) volumes and function, LA volumes and function, and 3D LGE 150 
assessment of baseline left atrial fibrosis. Details of the methods used to quantify baseline 151 
LA fibrosis are available in the online supplement. Cine imaging was performed in an end-152 
expiration breathhold using a standard multislice bSSFP technique (effective TR 2.7msec, TE 153 
1.3msec, 1.4x1.4mm2 in-plane, slice thickness 10mm, 50 phases). 3D inversion recovery 154 
spoiled gradient echo (LGE) acquisition was performed with coverage to include the whole 155 
of the LA in axial orientation. (TR 5.5msec, TE 3.0msec, flip angle 25°, low-high radial k-space 156 
ordering, respiratory and ECG-triggering (end atrial diastole, maximum 120msec acquisition 157 
window, respiratory navigator leading with gating window 5mm ), 1.3x1.3x4mm3 (typically 158 
50 interpolated slices per acquisition, reconstructed to 0.94x0.94x2mm3), SPIR fat 159 
suppression, pixel bandwidth 540Hz, phase-encoding direction AP, parallel imaging: SENSE 160 
P-reduction (AP) factor 2, 32 channel phased array digital receiver coil). Average acquisition 161 
window onset was 296±40msec post R-wave, and end at 398±39msec, adjusted bespoke to 162 
each subject. GBCA dose was 0.2ml/kg Gadovist (Bayer HealthCare Pharmaceuticals, Berlin, 163 
Germany). 164 
 165 
Scan 1 (post-procedure) was performed using the same 3D LGE acquisition parameters as 166 
the baseline scan, and a total of three LA 3D LGE datasets were acquired, timed to start at 167 
10minutes, 20minutes and 30minutes after GBCA administration. The inversion time was 168 
determined from a Look-Locker acquisition performed immediately prior to each LGE 169 
acquisition to ensure nulling of the myocardium. In rare cases in which the acquisitions took 170 
longer than 10minutes, the subsequent acquisition was started immediately. 171 
  172 
Scan 2 (post-procedure) was performed with allocated modifications of the baseline scan, 173 
with acquisitions again performed at 10min, 20min and 30min post GBCA administration.  174 
1. Reduced, single, gadolinium dose. 0.1mmol/kg of gadobutrol (Gadovist), otherwise 175 
unchanged 176 
2. Half-slice thickness. The acquired voxel size was reduced to 1.3x1.3x2mm 177 
(reconstructed 0.625x0.625x1mm). Field of view remained unchanged to cover the 178 
whole of the left atrium, and therefore approximately 90-100 slices were acquired, 179 
doubling the nominal acquisition duration. 180 
3. 3T scanner. Scans were performed on Philips Achieva 3T scanner with 32-channel 181 
coil. Parameters were matched to those for 1.5T scanning as closely as possible (TR 182 
4.0msec, TE 2.0msec, slice thickness 4mm, pixel bandwidth 620Hz, acquired voxel 183 
size 1.3x1.3x4mm3). 184 
 185 
Native T1-time constant assessment was performed prior to GBCA administration at each 186 
scan session in order to confirm myocardial washout. This was assessed using a balanced 187 
steady state free precession single breath-hold modified inversion recovery look-locker 188 
(MOLLI) sequence, in a single mid-ventricular short axis slice (TE: 1.64ms, TR 3.3ms, flip 189 
angle 50, voxel size 1.8x1.8x8mm, phase encoding steps n =166, 11 images from three 190 
inversions (3 +3 + 5) with three heartbeat pauses prior to the second and third inversions 191 
and an adiabatic prepulse). Myocardial T1 relaxation was measured at the septal 192 
myocardium with T1 time constant extrapolated from the exponential model fitted using 193 
ViewForum workstation (Philips Healthcare) [22]. 194 
Atrial fibrillation ablation protocol 195 
Two experienced operators performed all catheter ablation procedures under general 196 
anaesthesia using Carto3 (Biosense Webster/Johnson&Johnson, New Jersey, USA) 197 
electroanatomic mapping system, with the exception of 8 procedures performed using 198 
EnSite Velocity (St Jude Medical, St Paul, Minnesota, USA). For patients with a diagnosis of 199 
PAF and in sinus rhythm, a point-by-point wide area circumferential ablation (WACA) 200 
achieving PVI was performed using 8Fr irrigated SmartTouch catheter (Biosense Webster), 201 
or 8Fr irrigated TactiCath catheter (St Jude). Target ablation parameters were >5g for at 202 
least 15 seconds per RF delivery location. Power was 30W throughout except on the 203 
posterior wall, where it was limited to 25W. Procedural endpoint was defined as PV 204 
isolation as confirmed on entry block (and exit block if capture achieved). For patients 205 
presenting with PersAF, a WACA was performed followed by additional ablation lesion sets 206 
(mitral line, roof line, inferior posterior line, complex fractionated electrogram ablation) as a 207 
step-wise ablation.  208 
Imaging assessment 209 
Qualitative assessment 210 
Qualitative assessment of all acquisitions was performed independently by three 211 
experienced observers (HC, JH, SA). Observers were presented with a single representative 212 
transverse slice at the level of the aortic root in random order, with 10 initial training sets, 213 
and 20 random acquisitions repeated in order to assess intra-observer reproducibility. Likert 214 
Scale assessment was performed, with acquisitions graded across four criteria: image 215 
sharpness, scar contrast, freedom from artefact and quality of myocardial nulling. All criteria 216 
were scored from 1-5, with a score of 5 indicating optimal imaging within each criterion, as 217 
well as an average of all four criteria. 218 
Signal-to-Noise and Contrast-to-Noise ratios 219 
All acquisitions were analysed for signal-to-noise (SNR) and contrast-to-noise (CNR) ratios. 220 
In the presence of parallel imaging, noise is spatially heterogeneous throughout the imaging 221 
field, and should ideally be quantified through the assessment of multiple (>10) identical 222 
acquisitions. However, this is not feasible on account of the substantial additional imaging 223 
time, and the shifting tissue signal intensities during the acquisition following GBCA 224 
administration.  225 
 226 
Apparent SNR (aSNR) and apparent CNR (aCNR) were therefore calculated as the 227 
relationship between the mean signal intensity within a circular region of interest (ROI) 228 
within the blood (SIBlood) , the mean of a ROI within scar (SIScar), and the standard deviation 229 
of the background signal within the lungs (SDL) [23]. 230 
 231 
𝑎𝑆𝑁𝑅𝑆𝑐𝑎𝑟 =  
𝑆𝐼𝑆𝑐𝑎𝑟
𝑆𝐷𝐿
 232 
 233 
𝑎𝑆𝑁𝑅𝐵𝑙𝑜𝑜𝑑 =
𝑆𝐼𝐵𝑙𝑜𝑜𝑑
𝑆𝐷𝐿
 234 
 235 
𝑎𝐶𝑁𝑅 = 𝑎𝑆𝑁𝑅𝑆𝑐𝑎𝑟 − 𝑎𝑆𝑁𝑅𝐵𝑙𝑜𝑜𝑑 236 
 237 
ROIs were all selected within the same transverse slice, at the level of the origin of the left 238 
main coronary artery. For SIBlood, a 200mm2 circular ROI was placed in the LA blood pool, 239 
distant from potential artefact due to inflow enhanced by respiratory navigator signal; for 240 
SIScar, a 5mm2 ROI within the most intense region of PAAS within slice, and for SDL a 200mm2 241 
ROI within the lung, distant from any apparent large blood vessels at the same distance 242 
from the surface coils as the blood pool ROI. It was noted that the ROI for scar was small, 243 
and the value was therefore validated against the highest intensity scar on the 3D shell (see 244 
below). For acquisitions performed at 10min, the single ROI scar value was above a median 245 
of 98.8% (IQR 91.3-99.7%) of all atrial wall values for that acquisition. At 20min, the figure 246 
was 99.4%(98.5-99.7%) and at 30min 99.3% (IQR 98.8-99.8%). 247 
 248 
Scar quantification and quality of scar identification 249 
Details of the method used to quantify LA scar are documented in the online supplement. In 250 
brief, the LA endocardial border was segmented from the 3D LGE dataset, using a high 251 
contrast gated magnetic resonance angiogram as a template. The scar was interrogated 252 
using a maximum intensity projection technique (3mm outside segmented shell, 1mm 253 
within) and signal intensity values projected onto the 3D surface of the LA shell. For basic 254 
analysis, PAAS was thresholded at a single value of 3.3 standard deviations (SD) above the 255 
blood pool (BP) mean in accordance with histologically validated data [13], and expressed as 256 
a percentage of the total surface area of the LA (%PAAS). Further analysis was also 257 
performed in view of the confounding factors arising from the use of the single scar 258 
threshold: it is highly unlikely that a single threshold reflects the appropriate threshold for 259 
PAAS at all timings post GBCA administration. However, there is no published data to enable 260 
the rational selection of variable thresholds, and therefore the level of noise and quality of 261 
scar identification at equivalent thresholds at each timepoint was assessed. 262 
 263 
Firstly, the %PAAS was identified for the 20min post-GBCA acquisition at two published 264 
thresholds (3.3SD above the BP mean at 20min post-GBCA [13], and image intensity ratio 265 
(IIR) 1.32 at 20min post-GBCA [24]). Thresholds were then identified for the shells acquired 266 
at 10min and 30min post-GBCA in order to achieve the same scar burden (%PAAS). Finally, 267 
in order to assess the quality of scar identification, the point-by-point location of 268 
thresholded scar was compared to the location of ablation lesions. In a subset of 20 269 
patients, the electroanatomic map (EAM) shell (Carto3, Biosense Webster) was exported 270 
with objective lesion markers appended (VisiTag, Biosense Webster (thresholds: force 8g, 271 
time 10sec, 50% percentage time, range 3mm, impedance drop and target temperature 272 
thresholds ‘off’ [25]). The MRI-derived shells were fused to the EAM shell using an iterative 273 
closest point technique, blinded to MRI scar, and a Sorensen dice similarity coefficient (DSC) 274 
was used to analyse co-location of thresholded CMR LGE scar and ablation lesions [26].  275 
              𝐷𝑆𝐶(𝑇ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑(𝑇))) =   
2(𝑆𝑐𝑎𝑟𝐶𝑀𝑅 ∩ 𝐿𝑒𝑠𝑖𝑜𝑛𝐸𝐴𝑀)
𝑆𝑐𝑎𝑟𝐶𝑀𝑅 + 𝐿𝑒𝑠𝑖𝑜𝑛𝐸𝐴𝑀
 276 
 277 
where DSC(Threshold(T)) is the DSC for the comparison of the fused 278 
CMR shell with the ablation location EAM shell, at signal intensity 279 
threshold T. ScarCMR are the faces designated as scar on the CMR 280 
shell, at Threshold(T), and LesionEAM are the faces associated with an 281 
objective ablation marker (VisiTag). 282 
 283 
A DSC was derived for each acquisition, using the threshold at 10min and 30min that gave 284 
the same %PAAS as the ‘standard’ threshold at 20min. A high DSC represents good co-285 
location of PAAS and ablation lesions, with lower DSC at fixed scar burden likely to represent 286 
inappropriate assignation of scar at locations distant to ablation.  287 
 288 
Statistical analysis 289 
Data are expressed as mean (± standard deviation) for normally distributed data, and 290 
median (with interquartile range (IQR)) for non-normally distributed data. Statistical analysis 291 
was performed using IBM SPSS Statistics (Version 22,  Armonk,  NY). Baseline parameters 292 
were compared using unpaired t-test for normally distributed continuous variables, Mann-293 
Whitney U test for non-parametric variables and 2-test for categorical data. For Likert 294 
scores Intraclass correlation coefficient (ICC) was assessed using a two-way mixed effects 295 
model (average measures, alpha model). Assessment was for consistency for interobserver, 296 
and absolute agreement for intra-observer, and are quoted with 95% confidence interval 297 
(CI) [27], and two-way ANOVA was used to compare imaging parameters and timing of 298 
acquisition. Two-way ANOVA (repeated measures) was used to assess the effect of the scan 299 
parameters and timing of acquisition on aCNR and %PAAS area. The normality of the 300 
dependent variables was confirmed for all groups using Shapiro-Wilk’s test, except for the 301 
10min acquisitions for the ‘half-slice thickness’ group and the ‘3T’ group (both p<0.01). In 302 
order to exclude the strong time-related contribution of the acquisitions performed at 303 
10min, and to assess the change in imaging between acquisitions performed at 20 and 304 
30min, a further two-way ANOVA (repeated measures) was performed excluding the 305 
acquisitions at 10minutes. The effect of timing of acquisition alone was further assessed for 306 
‘standard’ acquisition parameters only: the studentized residuals were not normally 307 
distributed (Shapiro-Wilk’s) and therefore Wilcoxon matched-pairs signed rank test was 308 
used to compare side-by-side time points, and Friedman test for overall effect of acquisition 309 
time. P-values are quoted following Bonferroni correction for multiple comparisons where 310 
applicable.  311 
Results 312 
The MR imaging sets for 40 subjects were evaluated. In total, there were 40 datasets (one 313 
per subject) acquired prior to ablation and 231 datasets post-acquisition (271 out of 314 
maximum possible 280, 96.7%). Typical imaging with each set of imaging parameters is 315 
illustrated in Figures 2-5. Of the nine 3D LGE acquisitions not performed, three were at Scan 316 
1 (patient tolerance), three at the standard scan 2 (single patient with viral illness), one at 317 
single gadolinium dose scan 2 (patient tolerance) and two from 3T scan 2 (patient tolerance) 318 
(Figure 1). Myocardial T1 time at scan 1 was 989±21msec, and at scan 2 was 987±22msec 319 
(paired t-test p=0.34, subjects allocated to 3T excluded). 320 
 321 
Subject baseline demographics are summarised in Table 2. There were no significant 322 
differences between patients allocated to 1.5T versus 3T scanner. 323 
Likert scale assessment of imaging quality 324 
Imaging quality in terms of sharpness, scar contrast and overall score improved with time 325 
from GBCA administration across all imaging parameter sets (p<0.0001), whilst freedom 326 
from artefact and quality of myocardial nulling remained unchanged (Figure 6). Between 327 
imaging parameter sets, imaging at 3T had a lower overall imaging score, primarily driven by 328 
inferior sharpness and increased artefact. Imaging quality scores for the other imaging 329 
parameter sets demonstrated no significant differences when corrected for multiple 330 
comparisons. A subanalysis of the comparisons between acquisitions at 20min and 30min 331 
only was also performed. There was no significant difference in any comparison except for 332 
‘Contrast’ when standard acquisition parameters (p=0.012) or all acquisitions (p=0.003) 333 
were compared (see supplementary table 1). Likert score assessment was evaluated for 334 
reliability, and there was generally good interobserver consistency (ICC=0.888 (95% CI 335 
0.862-0.910)) and excellent intraobserver agreement (ICC=0.964 (95% CI (0.939-0.979)) 336 
(Table 3). Imaging acquisitions where myocardial nulling did not receive at least a score of 3  337 
(‘Good’) from all three observers were excluded from further analysis (n=7 out of 231, 3%).  338 
Timing of LGE acquisition 339 
Following GBCA administration, 3D LGE acquisitions were targeted to be commenced at 10, 340 
20 and 30min (performed at median 10min (IQR 9-12min), 22min (IQR 20-24min) and 32min 341 
(IQR 30-35min) respectively). The small drift in true rather than intended acquisition time 342 
reflects acquisition times >10min, and also operator time taken to compensate for 343 
inadequate respiratory navigator signal, respiratory gating efficiency, low heart rate, and 344 
patient-related delays such as anxiety. Total acquisition time for the sequence was broadly 345 
similar at all time intervals (6.4±3.1min at 10min, 6.7±2.5min at 20min and 7.3±3.5min at 346 
30min (p=0.06, repeated measures ANOVA)) and there was no significant change in the 347 
estimator of noise (SD of lung: 3.3±1.7 at 10min, 3.2±1.9 at 20min, 3.0±1.8 at 30min 348 
(p=0.31, repeated measures ANOVA)). 349 
 350 
Figure 7 shows the effect of acquisition timing on blood pool aSNR, scar aSNR, aCNR and 351 
fixed threshold (3.3SD above BP mean) overall scar area (%PAAS), for standard acquisitions 352 
only (n=49 at each time point, total 147 3D datasets). For all parameters there was a 353 
significant change with time: blood pool aSNR fell (p=0.009), as scar aSNR, aCNR and scar 354 
area all increased (p=0.0016, p<0.0001 and p<0.0001 respectively). For blood pool and scar 355 
aSNR, there was no significant change with Bonferroni correction between 20 and 30min 356 
(median 32.6 (IQR 23.6-56.6) versus median 33.9 (IQR 23.8-43.3) (p=0.06) and median 69.6 357 
(IQR 47.2-93.9) versus median 71.4 (IQR 47.3-90.3) (p=0.60) respectively). However, post-358 
processing of atrial scar is heavily reliant on the interaction of these two factors, and both 359 
aCNR (median 29.3 (IQR 18.3-47.3) versus median 34.7 (IQR 23.2-48.5) (p=0.0027)) and 360 
%PAAS area at fixed threshold (median 17.9% (IQR 11.7-28.5%) versus median 24.1% (IQR 361 
19.2-35.2%) (p<0.0001)) were lower at 20 than 30min. 362 
 363 
PAAS thresholds at 10 and 30min post-GBCA were derived that achieved the same %PAAS as 364 
‘standard’ thresholds at 20min: these are shown in Figure 8, again for standard parameters 365 
only. A markedly less stringent threshold was required at 10min in order to achieve the 366 
same %PAAS as at standard threshold at 20min (1.80±1.09 SD from BP mean or IIR 1.15 ± 367 
0.09 versus standard 3.3SD from BP mean or IIR 1.32 respectively (both p<0.0001)). 368 
Conversely, a more stringent threshold could be applied at 30min whilst achieving the same 369 
scar burden (4.37±1.30SD from BP mean or IIR 1.50±0.19 (both p<0.0001)). The DSC at 370 
20min, assessing colocation of ablation lesions and scar, was 0.37 ±0.11. This was 371 
significantly higher than the DSC observed at 10min using threshold to achieve the same 372 
%PAAS (0.27±0.12, p<0.0001), but lower than that observed at 30min (0.39±0.11, p=0.02). 373 
 374 
Scan parameters 375 
The effect of scan parameters on aCNR are shown in Figure 9. The effect upon blood pool 376 
and scar aSNR are shown in the online supplement (additional figures 1 and 2). Timing of 377 
the acquisition post GBCA administration remained an important determinant of aCNR 378 
across all imaging parameters (p<0.005 to p=0.023), except for the cohort randomised to 379 
single GBCA dose, where the impact of scan parameter dominated (time: p=0.529, scan 380 
parameters: p<0.0001). There was no statistically significant interaction between scan 381 
parameters and acquisition timing for all analyses (p=0.08 to p=0.96). 382 
 383 
For the control group, with identical scanning parameters in scan sessions 1 and 2, there 384 
was no significant difference between scan sessions. Single GBCA dose increased the aCNR 385 
(p<0.0001). At half slice thickness, there was no significant change in aCNR (p=0.77). One 386 
potential factor to account for the absence of decrease in aCNR could have been the timing 387 
of the acquisitions, if half-slice acquisitions were significantly later due to over-run of the 388 
longer acquisition. However, there was no significant difference at any time point for scan 1 389 
versus scan 2 acquisition commencement times (10min: 11.6±4min versus 10.3±1.4min 390 
(p=0.31), 20min: 23.2±5.4min versus 23.3±3.3min (p=0.95), 30min 35.5±6.8min versus 391 
34.1±4.6min (p=0.51) respectively). For 3T bore strength there was no significant difference 392 
in aCNR (p=0.12). 393 
 394 
A subanalysis of the impact of timing of acquisition was also performed with the 10minute 395 
acquisitions excluded, in view of the relatively poor imaging performance at this time point. 396 
aCNR did not differ significantly between 20min and 30min for any group.  397 
 398 
Discussion 399 
The quality of 3D LGE imaging of PAAS varies widely between different scanning 400 
parameters. This has important implications for the routine performance of these scans 401 
and, in particular, clinical decision making on the basis of MR-defined metrics. The findings 402 
are summarised as follows: 403 
1. Imaging quality improves with time from GBCA administration and LGE imaging with 404 
standard parameters is best performed 30min after injection of contrast  405 
2. A reduced, single dose of GBCA (0.1mmol/kg) improved aCNR without significant 406 
detrimental effect upon imaging quality 407 
3. Halving slice thickness reduced the amount of PAAS detected at standard threshold 408 
4. Imaging at 3T magnet strength did not improve aCNR in this patient cohort, and was 409 
associated with a reduction in imaging quality and amount of scar detected 410 
Timing of acquisition 411 
The finding that aCNR and scar detection increased with time is not surprising. In an 412 
informative study by Goldfarb et al [28], they documented the T1 values for left ventricular 413 
myocardial scar, viable myocardium and blood pool at two minute intervals following GBCA 414 
administration. Assessment was continued for up to one hour, and it was found that 415 
discrimination between scar and viable myocardium was significant even at very early 416 
acquisitions (<10min). However, the discrimination between blood pool and scar was only 417 
significant at >10min, and continued to improve with time, such that imaging at >30min was 418 
recommended for blood pool to scar differentiation. 419 
 420 
For PAAS imaging, it is the blood pool to scar differentiation that is crucial, not viable 421 
myocardium to scar. All centers currently acquire 3D LGE imaging with in-plane resolution 422 
around 1.3x1.3mm (Table 1), and therefore blood pool partial voluming effects are 423 
inevitable for most voxels within an atrial wall of thickness 2-4mm [29,30]. PAAS detection 424 
will be improved as the blood pool signal falls, regardless of the image interrogation 425 
technique. This is most critical when the maximum intensity projection technique is used to 426 
interrogate scar [3,8–10], but the principle also applies for a voxel-by-voxel interrogation of 427 
the atrial wall [2,7,11,31].  428 
 429 
In addition, it should be noted that the ‘true’ threshold for atrial scar, if it is even 430 
appropriate to binarise scar and healthy atrial myocardium at all, almost certainly changes 431 
with timing of acquisition. 3.3 SD from the BP mean was selected as an objective threshold 432 
with histological validation [13], but those pre-clinical scans were only performed at 433 
approximately 20minutes post GBCA administration, and the confidence intervals were 434 
wide. Likewise, an equivalent threshold of IIR 1.32 at 20min was also selected in view of 435 
demonstrated clinical correlation, but the derivation of the threshold was from ventricular 436 
myocardial imaging [24].  437 
 438 
Clearly, there will be a tight correlation between aCNR and %PAAS at a fixed threshold, and 439 
the increase in %PAAS scar detected with time should be interpreted with caution. At earlier 440 
acquisitions, the ‘true’ threshold, representing an optimal compromise of sensitivity and 441 
specificity, is likely to be lower as the scar signal intensity lies closer to that of the blood 442 
pool. Instead, increasingly high thresholds may be best viewed as an index of the confidence 443 
with which portions of the atrial shell may be classified as neither BP nor healthy 444 
myocardium. The innate advantage of the maximum intensity projection technique and the 445 
‘z-score’-type threshold is that it provides a degree of quantification of the likelihood that a 446 
signal intensity on the shell could possibly be derived from a BP voxel. Further work is 447 
required in order to define the appropriate thresholds for delineation of PAAS at different 448 
timings post GBCA, but this study has suggested that there is a decrease in the level of noise 449 
in scar detection with time from GBCA administration. The lower panels of Figure 8 show 450 
that areas that have not been ablated may be inappropriately delineated as scar at early 451 
acquisitions. Later acquisitions, using a higher threshold, are less likely to detect 452 
coincidental noise thus increasing confidence in scar (higher specificity for PAAS detection at 453 
later acquisitions). The improvement in DSC, reflecting appropriate scar detection, from 454 
20min to 30min was small but significant.  455 
 456 
The DSC values obtained in this study are lower than those found in a benchmark study 457 
comparing post-ablation scar locations to expert-derived pseudo-truth (0.72 - 0.85 for 458 
algorithm-derived scar, 0.14 - 0.59 for fixed thresholds) [32]. However, it is important to 459 
consider that there are two additional factors that will contribute to a DSC lower than those 460 
achieved for analysis of PAAS on the same raw image. Firstly, for this study PAAS was 461 
compared to ablation on a different LA anatomical shape, acquired on electroanatomic 462 
mapping. There will inevitably be regions of mis-registration of the relatively narrow bands 463 
of scar. Secondly, scar location is clearly not perfectly recorded on EAM. An average location 464 
of energy delivery is recorded, but is confounded by contact force, stability, and other 465 
determinants of scar formation. Therefore, many locations where energy is delivered will 466 
not have true scar formation. An average DSC of 0.39 is therefore in the anticipated range 467 
for a good assessment of ablation scar. 468 
 469 
The timing of 3D LGE acquisition varies widely in published studies, with no center routinely 470 
imaging at >30min (Table 1), although it should be noted that some vendors such as 471 
Siemens routinely acquire central k-space in the middle, rather than start, of the scan, 472 
effectively pushing the scan acquisition timing back by half of the scan duration compared 473 
to this study. There have been two large non-selective studies of PAAS imaging, where CMR 474 
imaging was performed regardless of recurrence status. Both acquired 3D LGE sequences at 475 
around 15min post-GBCA administration and gaps in ablation lines were frequently 476 
detected. Badger and co-workers detected gaps in PV scar at 405/576 veins (70%) and in 477 
93% of patients overall [3]. Akoum and co-workers, on assessment of a subset of the 478 
DECAAF study, detected circumferential scar at 1.26 veins per patient (gaps estimated at 479 
67% of veins) and also in 93% of patients overall [2]. The findings of the present study 480 
suggest that the incidence of gaps may hypothetically have been substantially lower if image 481 
acquisition had been delayed until later after GBCA administration. 482 
Scan parameters 483 
The improvement in PAAS imaging with reduced, single, GBCA dose relates largely to the 484 
increase in blood-pool-to-scar-contrast, and the superiority is most marked at early 485 
acquisitions. The persistence of the improved aCNR at 20 and 30min is an interesting 486 
illustration of the aphorism that ‘less is more’ and is not necessarily apparent from first 487 
principles: this is an important finding of this study. The relationship between contrast 488 
concentration and signal intensity is not a linear one, and the halving of contrast 489 
concentration in any given compartment does not necessarily result in a halving of 490 
relaxation rate (the inverse of the relaxation time constant). Similarly, the increase in signal 491 
resulting from a shortened T1 time-constant is a relationship that is also highly dependent 492 
upon inversion time and repetition time [33]. Furthermore, the time dependent 493 
concentrations of GBCA within the blood pool and atrial myocardial scar compartments 494 
have not been clearly ascertained [33].  495 
 496 
The lack of improvement in imaging at 3T may be explained at least in part by challenges in 497 
image acquisition that are more frequently encountered in this environment. ECG 498 
interference is higher, leading to triggering errors, and the respiratory navigator is less 499 
reliable, although once successfully commenced overall acquisition time was unchanged 500 
from controls. Contrast behavior is also relatively unchanged, with minimal reduction in 501 
relaxivity of GBCAs at higher field strengths (5.0mmol-1s-1, (range 4.7-5.3mmol-1s-1) at 3T in 502 
plasma, versus 5.2mmol-1s-1 (range 4.9-5.5mmol-1s-1) at 1.5T) [34]. However, the acquisition 503 
window was late atrial diastole (onset 296±40msec post R-wave), which was more 504 
frequently impinged upon at the longer inversion times necessary for imaging at 3T, 505 
requiring compromise in terms of acquisition window. The mean inversion times at 10min, 506 
20min and 30min were 238msec, 267msec and 288msec respectively, and the acquisition 507 
window had to be delayed for one subject at 10min, two at 20min and four at 30min. 508 
Generally the impingement upon the window was only by 10-20msec, but the maximum 509 
impingement for any subject was 80msec, markedly increasing the nominal acquisition time. 510 
Finally, many of the acquisition parameters clearly cannot be directly transposed from the 511 
1.5T to 3T environment, and in particular compromises regarding receiver bandwidth, TE 512 
and TR had to be made, which may also have impacted upon imaging quality.  513 
 514 
There was a general decline in imaging quality with half-slice thickness, which is not 515 
surprising. The reduced voxel size will decrease the voxel SNR, but on direct image 516 
assessment the blood pool and scar aSNR remained relatively preserved, as was aCNR 517 
(supplementary figures 1 and 2). However, when defining scar tissue at 3.3SD above BP 518 
mean there was a significant decrease in PAAS area overall. This has implications for the 519 
detection of small gaps. In the recent study by Bisbal et al, they found median gap size of 520 
13mm, but the smallest was 1.6mm [7], and Ranjan et al detected deliberate gaps as small 521 
as 1.4mm, using a 1.0x1.0x1.5mm resolution 3D LGE acquisition in an animal model [14]. 522 
Small gaps will only be detectable within plane for thicker slice 3D acquisitions, and not if 523 
the gap lies between slices. Two consecutive orthogonal acquisitions may represent the best 524 
compromise for accurate gap detection whilst maintaining scar sensitivity, but would 525 
require more complex registration and co-processing for gap detection. 526 
Clinical implications 527 
PAAS imaging in the immediate term presents opportunities for non-invasive evaluation of 528 
conventional and novel therapies. This includes assessment of the impact of contact force 529 
[35], evaluation of ablation extent by cryoballoon [36], and even ablation-induced 530 
modification of fat pads containing ganglionated plexi [37]. Optimal, and ideally uniform, 531 
imaging acquisition parameters would increase precision and facilitate comparison of 532 
studies. 533 
 534 
The use of PAAS imaging to guide ablation procedures is more controversial. Interscan 535 
reproducibility needs to be demonstrated, and sensitivity needs to improve. However, if the 536 
findings of Bisbal et al can be replicated then there is opportunity for swifter and more 537 
efficacious re-do procedures [7]. This may become even more relevant in the light of the 538 
PRESSURE trial where it was demonstrated that there was increased arrhythmia free 539 
survival with prophylactic repeat ablation procedure at 2months, regardless of recurrence 540 
status [38]. Non-invasive CMR correlates that identify subjects who would benefit from pre-541 
emptive repeat procedures could be extremely valuable. 542 
 543 
For post-ablation macro re-entry arrhythmias, identification of PAAS may also assist in the 544 
pre-procedural prediction of the arrhythmia mechanism. This in turn may inform activation 545 
mapping strategy, diagnostic manoeuvres and possibly lesion delivery. Zahid et al used atrial 546 
LGE datasets to derive patient specific models of LA tachycardia pathways, in combination 547 
with fibre orientation atlas. In 7 out of 10 patients (all post–PVI) it was possible to model a 548 
LA macro-reentrant circuit, and the ablation trajectory that was successful clinically was 549 
predicted in-silico in all 7 patients [39].  550 
Limitations 551 
This study was performed at 3 months post ablation, using Gadovist as the GBCA, and is an 552 
evaluation of chronic scar formation. As such, the results are not directly applicable to the 553 
assessment of acute lesion formation, and could not be used to guide acute repeat ablation 554 
during the index procedure in a hybrid-type environment. Likewise, there is evidence that 555 
there is a slow fading of scar with time [40], and the application of these results to imaging 556 
>3months post-ablation, or using different contrast agents, should be performed with 557 
caution.  558 
 559 
There is no gold standard for validation of PAAS detection, in the absence of histological 560 
assessment. Manual segmentation was considered, but strongly relies upon subjective user-561 
defined thresholding of the scar and was therefore rejected. Voltage mapping has been only 562 
weakly correlated with PAAS, and it is likely that registration errors, bipolar sampling 563 
considerations and electrode size confer upon voltage mapping a similar level of error as 564 
CMR assessment of scar. Furthermore, there is evidence that voltage and true scar are only 565 
moderately well-correlated [19]. Therefore, the study has focused on optimising sensitivity, 566 
rather than evaluations of specificity of scar detection. 567 
 568 
In terms of the study design and the analysis of the impact of the timing of the acquisition 569 
post-gadolinium, it is important to note that the study is underpowered to detect small 570 
differences with time from GBCA administration for the non-standard acquisition 571 
parameters. In addition, the acquisitions could not be performed at identical timepoints 572 
post-GBCA administration, which may introduce a bias for late acquisition for patients that 573 
experienced more difficult and prolonged imaging acquisitions. On account of technical 574 
considerations, it was not possible to randomize patients to the 3T scanner, and additionally 575 
scanning parameters cannot be replicated exactly between different scanner field strengths. 576 
The 3T acquisition parameters aimed for equivalence, rather than optimisation for 3T 577 
imaging alone, and the results at the higher field strength should be interpreted with 578 
caution. The interval between scan sessions was minimized in order to control for time 579 
dependent scar maturation [40], but there was  a possibility of residual GBCA accumulation 580 
between scans. T1 relaxation times for the myocardium were unchanged between scan 581 
sessions, and there was no systematic difference between scans in any parameter for 582 
control patients. Recent studies have suggested that very low concentrations may persist 583 
beyond 48 hours [41], despite the interval being >20 half-lives, but the impact on the results 584 
is likely to be minimal. 585 
Conclusions 586 
Qualitative image quality (sharpness, scar contrast and overall quality score) improves with 587 
time after GBCA administration (from 10 minutes to 30 minutes). Quantitatively, blood pool 588 
aSNR decreases while scar aSNR, aCNR and fixed-threshold %PAAS increase. In a sub-589 
analysis comparing acquisitions at 30 minutes and 20 minutes post GBCA, both qualitative 590 
and quantitative measures of CNR were higher at 30 minutes. A reduced, single, dose of 591 
GBCA is superior in terms of contrast-to-noise ratio, whilst reduced slice thickness and 592 
imaging at 3T tend to result in inferior imaging quality.  593 
 594 
List of abbreviations 595 
 596 
AF- atrial fibrillation 
BP- blood pool 
aCNR- apparent contrast-to-noise ratio 
aSNR- apparent signal-to-noise ratio 
CI- confidence interval 
CMR- cardiac magnetic resonance 
CNR- contrast-to-noise ratio 
ECG- electrocardiogram 
GBCA- gadolinium based contrast agent 
GMRA- gated magnetic resonance 
angiogram 
ICC- intraclass correlation coefficient 
IQR- interquartile range 
LA- left atrium 
LAA- left atrial appendage 
LGE- late gadolinium enhancement 
PAAS- post-ablation atrial scar 
PAF- paroxysmal atrial fibrillation 
PersAF- persistent atrial fibrillation 
PV- pulmonary vein 
RF- radiofrequency 
SD- standard deviation 
SI- signal intensity 
SNR- signal-to-noise ratio 
TE- echo time 
TR- repetition time 
WACA- wide area circumferential ablation 
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Figure Legends 
 
Figure 1. Flowchart demonstrating subject allocation and number of scan 
acquisitions achieved. 
 
Figure 2.  Typical imaging results with identical scan protocol for scan 1 and 2. 
Note clearly enhanced regions in imaging performed at 30min post gadolinium-
based contrast agent administration, representing post-ablation atrial scar. 
Slight variations between scan sessions were common at 10min, where contrast 
was changing most rapidly, but stabilised by 30min. 
 
Figure 3. Typical imaging with reduced, single, gadolinium dose for Scan 2.  
 
 
Figure 4.  Typical imaging with half slice thickness for Scan 2. 
 
 
Figure 5. Typical imaging with Scan 2 performed at 3T. 
 
 
Figure 6. Summary of Likert Scores for each set of imaging acquisition 
parameters 
See above for full details of imaging parameters. The blue, green and red columns 
indicate imaging performed at 10min, 20min and 30min post GBCA injection 
respectively. P-values for two-way ANOVA. 
 
Figure 7. Relationship of acquisition timing post GBCA administration and 
signal/contrast-to-noise ratios. 
(Top left) apparent blood pool signal-to-noise ratio (SNR), (top right) apparent scar 
SNR, (bottom left) apparent scar to blood pool contrast-to-noise ratio, and 
(bottom right) LA scar area as a percentage of left atrium, thresholded at 3.3 
standard deviations above blood pool mean. Values presented are for standard 
acquisition parameters only (n=49 at each time point). For each plot, three p-
values are presented: the top is p-value for Friedman test, assessing overall impact 
of time, and the bottom two are the p-values for Wilcoxon matched-pairs signed 
rank test. 
Figure 8. Impact of acquisition timing upon PAAS thresholding and quality of scar 
imaging. Charts (upper panels) show the change in threshold required for the 
acquisitions at 10min and 30min in order to achieve the same total %PAAS as that 
observed at 20min at 3.3standard deviations (SD) above the blood pool (BP) mean 
(left- red line at 3.3) and BP image intensity ratio (IIR) 1.32 (right- red line at 1.32). 
Lower panels show the impact of changing time and threshold on scar location for 
a typical subject, with identical scar burden for all acquisitions. The true ablation 
lesion locations are shown in yellow on left, with thresholded scar in three 
subsequent panels to the right. Note clearest delineation of scar at 30min. LUPV: 
left upper pulmonary vein (PV), RUPV: right upper PV, LLPV: left lower PV, RLPV: 
right lower PV, TSP: trans-septal puncture site. 
 
Figure 9. Impact of scan parameters on apparent scar to blood pool contrast-to-
noise ratio.  
Paired acquisitions at 10, 20 and 30min post GBCA injection, for control subjects 
(top left), reduced, single, GBCA dose (top right), half slice thickness (bottom left) 
and 3T scanner (bottom right). Scan 1 (standard acquisition, circle) and scan 2 
(experimental acquisition, square) are linked for each subject. P-values are for 
two-way repeated measures ANOVA: at the bottom of each plot is the p-value for 
variance with time, and to the right is the p-value for variance with acquisition 
parameter. Unpaired acquisitions are shown as unlinked circle or square and were 
not included in statistical analyses. 
 
 
 
 
 
 
